LYELL IMMUNOPHARMA INC (LYEL) Stock Cash Flow
NASDAQ:LYEL - Nasdaq - US55083R1041 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -334.52M | -342.99M | -234.63M | -183.12M | -250.22M | |||
| Depreciation Amortization | 18.05M | 19.63M | 20.25M | 18.02M | 13.62M | |||
| Change In Working Capital | -9.44M | -3.12M | 3.42M | -82.02M | 4.02M | |||
| Other non cash items | 150.79M | 164.09M | 47.27M | 77.56M | 106.33M | |||
| OPERATING CASH FLOW | -175.12M | -162.39M | -163.69M | -169.56M | -126.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.03M | -31.81M | -2.69M | -24.28M | -65.50M | |||
| Other Investing Activity | 201.92M | 154.23M | 186.73M | 12.74M | -56.07M | |||
| INVESTING CASH FLOW | 169.90M | 122.42M | 184.05M | -11.54M | -121.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.30M | 1.40M | 2.20M | 11.10M | 401.24M | |||
| Other Financing Activity | 1.00K | -76.00K | -457.00K | -460.00K | N/A | |||
| FINANCING CASH FLOW | 1.30M | 1.33M | 1.74M | 10.64M | 401.24M | |||
| CHANGE IN CASH | -3.92M | -38.64M | 22.10M | -170.46M | 153.42M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -175.12M | -162.39M | -163.69M | -169.56M | -126.25M | |||
| Capital Expenditure | -32.03M | -31.81M | -2.69M | -24.28M | -65.50M | |||
| FREE CASH FLOW | -207.14M | -194.20M | -166.38M | -193.84M | -191.75M | |||
All data in USD